Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer-Reference-Cited by-同舟云学术

Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer

Published:2011-09 Issue:3 Volume:73 Page:345-350
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Hirose Takashi,Nakashima Masanao,Shirai Takao,Kusumoto Sojiro,Sugiyama Tomohide,Yamaoka Toshimitsu,Okuda Kentaro,Ohnishi Tsukasa,Ohmori Tohru,Adachi Mitsuru

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference29 articles.

1. Topotecan in small cell lung cancer;Schiller;Semin Oncol,1997

2. Recurrent small cell lung cancer: update;Glisson;Semin Oncol,2003

3. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer;von Pawel;J Clin Oncol,1999

4. Stereospecific total synthesis of 9-aminoanthracyclines: (+)-9-deoxydaunomycin and related compounds;Ishizumi;J Org Chem,1987

5. In vivo efficacy and tumor-selective metabolism of amrubicin to its active metabolite;Noguchi;Jpn J Cancer Res,1998

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between effectiveness of first-line treatment and second-line treatment in gastro-oesophageal cancer;European Journal of Cancer;2021-10

2. Second-line treatments of small-cell lung cancers;Expert Review of Anticancer Therapy;2017-09-08

3. Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I–inhibiting Antibody–Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan;Clinical Cancer Research;2017-07-05

4. Differenzialtherapie des fortgeschrittenen metastasierten kleinzelligen Lungenkarzinoms;Der Onkologe;2017-04-04

5. Low-dose Irinotecan as a Second-line Chemotherapy for Recurrent Small Cell Lung Cancer;Japanese Journal of Clinical Oncology;2014-07-23